Refractory Takayasu arteritis with recurrent pyoderma gangrenosum: a therapeutic challenge with case-based review-Reference-Cited by-同舟云学术

Refractory Takayasu arteritis with recurrent pyoderma gangrenosum: a therapeutic challenge with case-based review

Published:2023-01-13 Issue:5 Volume:42 Page:1469-1477
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Bhowmick Kaustav^ORCID,Roongta Rashmi^ORCID,Dey Soumya^ORCID,Dey Sonali^ORCID,Mondal Sumantro^ORCID,Sinhamahapatra Pradyot^ORCID,Ghosh Parasar^ORCID,Ghosh Biswadip^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-023-06506-x.pdf

Reference35 articles.

1. Zhang X, Jiao Y (2019) Takayasu arteritis with pyoderma gangrenosum: case reports and literature review. BMC Rheumatol 3:45. https://doi.org/10.1186%2Fs41927-019-0098-z

2. Acharya N, Chattopadhyay A, Das A, Jain S (2020) Takayasu arteritis with pyoderma gangrenosum and superficial thrombophlebitis. The Lancet Rheumatol 2(8):5-e510. https://doi.org/10.1016/S2665-9913(20)30088-6

3. Choong DJ, Ng JL, Vinciullo C (2021) Pyoderma gangrenosum associated with Takayasu’s arteritis in a young Caucasian woman and response to biologic therapy with tocilizumab. JAAD Case Rep 9:4–6. https://doi.org/10.1016/j.jdcr.2020.12.034

4. Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G et al (2021) American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol 73(8):1349–1365. https://doi.org/10.1002/art.41774

5. Borgia F, Sutera D, Spagnolo A, Mazza F, Bertino L, Cannavò SP, Gallizzi R (2021) Onset of pyoderma gangrenosum after tocilizumab therapy for Takayasu arteritis: a new undescribed paradoxical reaction. Br J Clin Pharmacol 87:3378–3379. https://doi.org/10.1111/bcp.14756

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STEMI Following In-Stent Restenosis in Coronary Takayasu Arteritis With Pyoderma Gangrenosum in a Teenaged Athlete;JACC: Case Reports;2024-09

2. Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review;Rheumatology International;2024-03-15

3. Tofacitinib for the treatment of severe rare skin diseases: a narrative review;European Journal of Clinical Pharmacology;2024-01-17

4. Tocilizumab;Reactions Weekly;2023-05-20

5. Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis;Cancers;2023-04-07